Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
tanespimycin (BMS-722782)
i
Other names:
BMS-722782, 17-AAG, 17-allylamino-17-demethoxy-geldanamycin, KOS-953
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(9)
News
Trials
Company:
BMS
Drug class:
HSP90 inhibitor
Related drugs:
‹
AUY922 (7)
ADX-1612 (6)
pimitespib (5)
IPI-504 (5)
AT13387 (4)
LAM 003 (3)
IPI 493 (2)
XL888 (2)
aminoxyrone (1)
KW 2478 (0)
NCT-547 (0)
OS47701 (0)
RGRN-305 (0)
SNX-2112 (0)
SNX-5422 (0)
gamitrinib (0)
PEN-866 (0)
PU-H71 IV (0)
AUY922 (7)
ADX-1612 (6)
pimitespib (5)
IPI-504 (5)
AT13387 (4)
LAM 003 (3)
IPI 493 (2)
XL888 (2)
aminoxyrone (1)
KW 2478 (0)
NCT-547 (0)
OS47701 (0)
RGRN-305 (0)
SNX-2112 (0)
SNX-5422 (0)
gamitrinib (0)
PEN-866 (0)
PU-H71 IV (0)
›
Associations
(9)
News
Trials
VERI cancer hierarchy
Reset Filters
PIK3CA E545K
Squamous Cell Carcinoma of Head and Neck
PIK3CA E545K
Squamous Cell Carcinoma of Head and Neck
BMS-722782
Resistant: D – Preclinical
BMS-722782
Resistant
:
D
BMS-722782
Resistant: D – Preclinical
BMS-722782
Resistant
:
D
PIK3CA H1047R
Squamous Cell Carcinoma of Head and Neck
PIK3CA H1047R
Squamous Cell Carcinoma of Head and Neck
BMS-722782
Resistant: D – Preclinical
BMS-722782
Resistant
:
D
BMS-722782
Resistant: D – Preclinical
BMS-722782
Resistant
:
D
EGFR exon 19 deletion
Lung Cancer
EGFR exon 19 deletion
Lung Cancer
BMS-722782
Sensitive: D – Preclinical
BMS-722782
Sensitive
:
D
BMS-722782
Sensitive: D – Preclinical
BMS-722782
Sensitive
:
D
EGFR T790M
Lung Cancer
EGFR T790M
Lung Cancer
BMS-722782
Sensitive: D – Preclinical
BMS-722782
Sensitive
:
D
BMS-722782
Sensitive: D – Preclinical
BMS-722782
Sensitive
:
D
EGFR L858R
Lung Cancer
EGFR L858R
Lung Cancer
BMS-722782
Sensitive: D – Preclinical
BMS-722782
Sensitive
:
D
BMS-722782
Sensitive: D – Preclinical
BMS-722782
Sensitive
:
D
EGFR H1975
Lung Cancer
EGFR H1975
Lung Cancer
BMS-722782
Sensitive: D – Preclinical
BMS-722782
Sensitive
:
D
BMS-722782
Sensitive: D – Preclinical
BMS-722782
Sensitive
:
D
ALK rearrangement
Lung Cancer
ALK rearrangement
Lung Cancer
BMS-722782
Sensitive: D – Preclinical
BMS-722782
Sensitive
:
D
BMS-722782
Sensitive: D – Preclinical
BMS-722782
Sensitive
:
D
MYB-TYK2 fusion
B Acute Lymphoblastic Leukemia
MYB-TYK2 fusion
B Acute Lymphoblastic Leukemia
vorinostat + BMS-722782
Sensitive: D – Preclinical
vorinostat + BMS-722782
Sensitive
:
D
vorinostat + BMS-722782
Sensitive: D – Preclinical
vorinostat + BMS-722782
Sensitive
:
D
ZNF765 overexpression
Hepatocellular Cancer
ZNF765 overexpression
Hepatocellular Cancer
BMS-722782
Resistant: D – Preclinical
BMS-722782
Resistant
:
D
BMS-722782
Resistant: D – Preclinical
BMS-722782
Resistant
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login